EcoR1 Capital LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | EcoR1 Capital LLC | 4,288,120 4.800% | 132,745 (+3.19%) | Filing |
| 2024-03-11 3:34 pm Purchase | 2024-02-28 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | EcoR1 Capital LLC | 4,155,375 5.300% | 4,155,375 (New Position) | Filing |